Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up

{{output}}

[This retracts the article DOI: 10.36185/2532-1900-058.]. ©2022 Gaetano Conte Academy - Mediterranean Society of Myology.

请注册登录后继续浏览